Serum BRD2 autoantibody in hepatocellular carcinoma and its detection using mimotope peptide-conjugated BSA

Tumor-associated (TA) autoantibodies are considered to be promising biomarkers for the early detection of cancer, prior to the development of clinical symptoms. In the present study, a novel TA autoantibody was detected, which may prove to be useful as a diagnostic marker of human HCC using an HBx-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Heo, Chang-Kyu, Lim, Won-Hee, Park, Inseo, Choi, Yon-Sik, Lim, Kook-Jin, Cho, Eun-Wie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635863/
https://www.ncbi.nlm.nih.gov/pubmed/36321789
http://dx.doi.org/10.3892/ijo.2022.5448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635863/
https://www.ncbi.nlm.nih.gov/pubmed/36321789
http://dx.doi.org/10.3892/ijo.2022.5448

Ejemplares similares